Mesothelioma News

This study is currently recruiting participants.Verified by National Cancer Institute (NCI) August 2007

Sponsors and Collaborators:

North Central Cancer Treatment GroupNational Cancer Institute (NCI)

Information provided by:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00459862

Purpose

RATIONALE: Pazopanib may stop the growth of tumor […]

June, 22 2007
A day after the the Minnesota Department of Health (MDH) came under fire for withholding information on additional cases of mesothelioma among Minnesota’s Iron Range workers, the department announced that six new cases of the cancer were found among the miners.
By Katherine Torres
In a group of 72,000 people who worked in the state’s […]

Lawsuit filed by New Jersey and New York mesothelioma attorneys from Levy Phillips & Konigsberg, LLP.
New York, NY (PRWEB) June 22, 2007 — The New York mesothelioma lawsuit involving Joel Rosenberg is proceeding to trial with a pre-trial conference scheduled before Justice Marcy S. Friedman, Supreme Court, New York County, in downtown Manhattan on June […]

By Peggy Peck, Managing Editor, MedPage Today
June 06, 2007
MedPage Today Action Points
* Explain to patients that two pemetrexed-platinum combinations demonstrated similar activity in unresectable malignant pleural mesothelioma.
* Note that the findings came from an expanded access program for pemetrexed rather than a randomized clinical trial.
[…]

By Cara Bailey -Kanawha Bureau
CHARLESTON - A former West Virginia couple filed an asbestos suit against 77 different companies, claiming the husband is ill because of their negligence concerning asbestos safety.
Donald and Virginia Schwartz, now residents of Arizona, filed a suit April 24 in Kanawha Circuit Court. Donald Schwartz was employed as a steamfitter, superintendent, […]

WASHINGTON–(BUSINESS WIRE)–May 9, 2007–The Asbestos Disease Awareness Organization (ADAO), an organization dedicated to serving as the voice of asbestos victims, today announced that an increasing number of patients suffering from asbestos-related diseases are now younger than in previous reports. Case reports from the past three years reveal a new median age of 51 and nearly […]

Rosetta Genomics, Ltd has announced that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.
The early detection test will mainly target over 45 million Americans who are at an increased risk of lung cancer due to smoking, as well […]

BLOOMFIELD, N.J., April 18, 2007 /PRNewswire-FirstCall/ — ONCONASE (ranpirnase), Alfacell Corporation’s lead drug candidate, may have potential as a chemopreventive agent, according to world-renowned mesothelioma researcher Michele Carbone M.D., Ph.D., at this week’s American Association for Cancer Research (AACR) Annual Meeting.
In a series of poster presentations, Dr. Carbone highlighted the growing worldwide problem of asbestos […]

DETROIT, April 17 /PRNewswire/ — The Barbara Ann Karmanos Cancer
Institute today announced significant scientific findings that could lead
to better treatment and therapies for cancer patients suffering from
malignant pleural mesothelioma.
Karmanos scientists presented their research at the American
Association of Cancer Research (AACR) annual meeting in Los Angeles, CA.
“We are getting closer and closer to making an impact […]

Suberoylanilide Hydroxamic Acid (SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma
This study is currently recruiting patients.Verified by Merck April 2007

Sponsored by:
Merck

Information provided by:
Merck

ClinicalTrials.gov Identifier:
NCT00128102

Purpose

This is […]